Acromegaly is due to hypersecretion of growth ... cutaneous or metabolic side effects. The authors concluded that long-term treatment with somatostatin analogs is effective and well tolerated.

Medication which blocks the effects of growth hormone and reduces IGF-I — Somavert (pegvisomant). Researchers at Federico II University of Naples in Italy studied 86 individuals with acromegaly who ...

Researchers conducted a retrospective study to investigate the predictive role of growth hormone paradox (GH-Par) on pasireotide response and adverse event development in patients with acromegaly.

Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).